Acción CANBD CAN B CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas Can B Corp. Other OTC

Acciones

CANBD

US13470W1036

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Can B Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
Can B : New Financial Obligation - Form 8-K
Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million
Can B Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Can B Corp. Expects Nearly $500,000 Annual Savings With Successful Completion of Move of Pure Health Products From Lacey, WA to Colorado
Can B Corp. Announces its Move and Consolidation of its Pure Health Product Operations from Lacey, WA to Colorado
Can B Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Can B Corp. Secures 1.8 Million Pounds of Biomass for Awarded Contract With One Bad Moon Rising
Can B Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Can B Corp. Reports Growth of 45% to Company All-Time High $6.7 Million Annual Revenue
CAN B CORP Management's Discussion and Analysis of Financial Condition and Results of Operation (form 10-K)
Can B Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Can B Corp. Auditor Raises 'Going Concern' Doubt
Can B Corp. Completes Corporate Debt Restructuring to Position for Uplisting to National Securities Exchange
CAN B CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities (form 8-K)
Can B Corp. announced that it has received $1.55 million in funding
Can B Corp. announced that it expects to receive $1.55 million in funding
Can B Corp. Reports Growth of 51% to $2.9 Million Revenue for Third Quarter 2022, the Highest Quarterly Revenue in Company History
CAN B CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Can B Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción CANB
  4. Acción CANBD
  5. Noticias Can B Corp.
  6. Otros idiomas